Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
Galileo 🔭
start up
United States
- San Francisco, California
- 16/10/2024
- Series B
- $45,000,000
Galileo is the leading platform for enterprise GenAI evaluation and observability. Our comprehensive suite of products support builders across the new AI development workflow—from fine-tuning LLMs to developing, testing, monitoring, and securing their AI applications. Each product is powered by our research-backed evaluation metrics. Today, Galileo is used by 100s of AI teams from startups to Fortune 50 enterprises, including Twilio, Comcast, and HP.
- Industry Software Development
- Website https://www.galileo.ai/
- LinkedIn https://www.linkedin.com/company/galileo-ai/
Related People
Vikram ChatterjiFounder
United States -
San Francisco, California
Building the enterprise-grade Evaluations and Observability platform for the AI software era, powered by Evaluation Foundation Models.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)